Risk factors for gastrointestinal bleeding in children with Henoch-Schönlein purpura

Dequan Su1, Mi Yang2, Xiaoqin Wang1

  • 1Department of Nephrology, Xiamen Hospital, Affiliated Children's Hospital of Fudan University (Xiamen Children's Hospital), Xiamen, China.

PubMed

Insights

Abdominal pain, elevated procalcitonin (PCT), and increased D-dimer levels are key risk factors for gastrointestinal bleeding in children with Henoch-Schönlein purpura (HSP). Early identification of these indicators aids in timely diagnosis and improved patient outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Rheumatology
  • Hematology

Background:

  • Henoch-Schönlein purpura (HSP) is a common vasculitis in children.
  • Gastrointestinal (GI) bleeding is a significant complication of HSP, impacting patient morbidity.
  • Identifying risk factors for GI bleeding in pediatric HSP is crucial for timely intervention.

Purpose of the Study:

  • To investigate the risk factors associated with gastrointestinal bleeding in pediatric patients diagnosed with Henoch-Schönlein purpura.
  • To improve early diagnosis, treatment strategies, and patient outcomes for HSP-related GI complications.

Main Methods:

  • A case-control study comparing 23 pediatric patients with HSP and GI bleeding to 44 patients with HSP without GI bleeding.
  • Data collection included clinical characteristics, laboratory results, and imaging findings.
  • Univariate and multivariate analyses were performed to identify independent risk factors.

Main Results:

  • Abdominal pain and intestinal wall thickening on ultrasonography were more frequent in the GI bleeding group (P < 0.05).
  • Significant differences were observed in eight laboratory parameters, including WBC, NE, NLR, PCT, CRP, D-dimer, Fib, and TT (P < 0.05).
  • Multivariate analysis identified abdominal pain (OR=2.334), PCT > 0.12 ng/ml (OR=10.010), and D-dimer > 1.87 mg/L (OR=3.407) as independent risk factors for GI bleeding.

Conclusions:

  • Abdominal pain, elevated procalcitonin (PCT), and increased D-dimer levels are significant independent risk factors for gastrointestinal bleeding in pediatric HSP.
  • Monitoring these indicators can enhance clinical management and improve outcomes for children with HSP.
  • Early recognition of these risk factors facilitates prompt treatment and complication prevention.
Abstract

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
104
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
51
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
306
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
168
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
479
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
159